Development of mass spectrometry-based assays to measure the ERCC1/XPF proteins as potential biomarkers in lung cancer

Biochemistry, Genetics and Molecular Biology

• Mass Spectrometry 100%
• Base Excision Repair 100%
• Isoform 20%
• DNA Damage 12%
• Nucleotide Excision Repair 8%
• Endonuclease 4%
• Decision Making 4%
• DNA Repair 4%
• Antibody Affinity 4%

Immunology and Microbiology

• Excision Repair 100%
• Peptides 20%
• DNA Damage 12%
• Decision Making 4%
• DNA Repair 4%
• Antibody Affinity 4%

Keyphrases

• Proteotypic Peptides 8%
• Immunoaffinity 4%
• Selective Approach 4%
• Endonuclease 4%
• Platinum Drugs 4%
• Therapy Response Prediction 4%
• Quality of Medical Care 4%
• Clinical Scenarios 4%
• Immunoenrichment 4%
• Analytic Specificity 4%
• Immunohistochemical Tests 4%
• Clinical Quality 4%
• Chemotherapy Efficacy 4%